Sökning: onr:"swepub:oai:DiVA.org:uu-24970" >
A unified definitio...
A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia : results of a consensus process by an international working group
-
Barosi, G. (författare)
-
Besses, C. (författare)
-
- Birgegård, Gunnar, 1944- (författare)
- Uppsala universitet,Institutionen för medicinska vetenskaper,Hematologi
-
visa fler...
-
Briere, J. (författare)
-
Cervantes, F. (författare)
-
Finazzi, G. (författare)
-
Gisslinger, H. (författare)
-
Griesshammer, M. (författare)
-
Gugliotta, L. (författare)
-
Harrison, C. (författare)
-
Hasselbalch, H. (författare)
-
Lengfelder, E. (författare)
-
Reilly, J. T. (författare)
-
Michiels, J. J. (författare)
-
Barbui, T. (författare)
-
visa färre...
-
(creator_code:org_t)
- 2006-11-16
- 2007
- Engelska.
-
Ingår i: Leukemia. - : Springer Science and Business Media LLC. - 0887-6924 .- 1476-5551. ; 21:2, s. 277-280
- Relaterad länk:
-
https://www.nature.c...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- A widely accepted definition of resistance or intolerance to hydroxyurea (HU) in patients with essential thrombocythemia (ET) is lacking. An international working group (WG) was convened to develop a consensus formulation of clinically significant criteria for defining resistance/intolerance to HU in ET. To this aim, an analytic hierarchy process (AHP), a multiple-attribute decision-making technique, was used. The steps consisted of selecting the candidate criteria for defining resistance/intolerance; identifying the motivations that could influence the preference of the WG for any individual criterion; comparing the candidate criteria in a pair-wise manner; and grading them according their ability to fulfill the motivations. Every step in the model was derived by questionnaires or group discussion. The WG proposed that the definition of resistance/intolerance should require the fulfillment of at least one of the following criteria: platelet count greater than 600,000/micro l after 3 months of at least 2 g/day of HU (2.5 g/day in patients with a body weight over 80 kg); platelet count greater than 400,000/micro l and WBC less than 2500/micro l or Hb less than 10 g/dl at any dose of HU; presence of leg ulcers or other unacceptable muco-cutaneous manifestations at any dose of HU; HU-related fever.
Nyckelord
- essential thrombocythemia
- hydroxyurea
- analytic hierarchy process
- resistance
- intolerance
- MEDICINE
- MEDICIN
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
-
Leukemia
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas
- Av författaren/redakt...
-
Barosi, G.
-
Besses, C.
-
Birgegård, Gunna ...
-
Briere, J.
-
Cervantes, F.
-
Finazzi, G.
-
visa fler...
-
Gisslinger, H.
-
Griesshammer, M.
-
Gugliotta, L.
-
Harrison, C.
-
Hasselbalch, H.
-
Lengfelder, E.
-
Reilly, J. T.
-
Michiels, J. J.
-
Barbui, T.
-
visa färre...
- Artiklar i publikationen
-
Leukemia
- Av lärosätet
-
Uppsala universitet